FDA approves 1st drug for hypertrophic cardiomyopathy April 29, 2022 Auto Bot News 0 The FDA on April 28 approved Bristol Myers Squibb’s Camzyos, the first drug to target the cause of obstructive hypertrophic cardiomyopathy.
